SORAHEET Tablet (Sorafenib)
|COUNTRY OF ORIGIN||India|
|PACKAGING||120 tablets in 1 bottle|
|MANUFACTURER||Heet Healthcare Private Limited|
Sorafenib Tablets IP 200mg
SORAHEET Tablet belongs to the group of medicine called ‘anti-cancer’ that is primarily indicated in the treatment of kidney, liver, and thyroid cancer. Kidney cancer is also known as renal cancer is a disease in which healthy cells of the kidney become malignant (cancerous), grow in an uncontrolled manner, and forms a tumour. Cancer of the liver is known as liver cancer. When cancer occurs in the liver, it destroys healthy cells of the liver and affects the ability of the liver to function normally. Thyroid cancer occurs when cells start multiplying in the thyroid gland and form a tumour. The tumour is a collection of abnormal cells.
SORAHEET Tablet contains ‘Sorafenib’ that falls in the category of medicines known as ‘kinase inhibitors’. It works by stopping the action of an abnormal protein that causes the multiplication of cancerous cells. In this way, it stops the spread of cancerous cells.
Take SORAHEET Tablet as prescribed by your doctor. You are suggested to take SORAHEET Tablet as long as your doctor has prescribed it after checking your medical condition. In some cases, you may experience certain common side-effects such as itching or skin rash, acne, dry skin, vomiting, diarrhoea, and loss of appetite. Most of these side-effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side-effects persistently.
To treat your condition effectually, continue taking SORAHEET Tablet for as long as your doctor has prescribed. Do not take SORAFENIB if you are pregnant or planning for pregnancy as SORAHEET Tablet causes serious birth defects. SORAHEET Tablet should not be taken by breastfeeding mothers as it passes into breast milk and may cause a possible risk to the infant. Elderly people are more sensitive to the medicine so the doctor may adjust the dosage according to the condition. Avoid consuming alcohol along with SORAHEET Tablet as it could lead to increased dizziness.
Uses of SORAHEET Tablet
Cancer (kidney, liver, and thyroid)
SORAHEET Tablet is a ‘ tyrosine kinase inhibitor (TKI)’, that stops the uncontrolled growth and spread of cancerous cells. SORAFENIB is effective in treating thyroid, liver and kidney cancer. It acts by stopping the action of the abnormal protein that is responsible for the multiplication of cancerous cells. Whenever a new healthy cell is formed it undergoes a usual process of maturity. Cancerous cells form new cells more quickly so SORAFENIB targets cancerous cells and block the action of Tyrosine kinases enzymes (responsible for causing cancer). In this way, SORAFENIB stops the production, spread and growth of cancerous cells in the body.
Directions for Use
Side Effects of SORAHEET Tablet
- Dry skin
- Loss of appetite
- Itching or skin rash
In-Depth Precautions and Warning
SORAHEET Tablet may make you more susceptible to infections; consult your doctor if you develop any signs of infections such as fever, sore throat, breathlessness, jaundice, unexplained bleeding, or bruising. Your doctor may advise you to undergo regular blood tests, kidney and liver tests to monitor your condition. Inform your doctor about your health condition and medicines to rule out any unpleasant side-effects. Before your doctor prescribes you SORAFENIB, tell them if you have heart problems, high blood pressure, bleeding issues, surgery, or an electrolyte imbalance (like abnormal levels of magnesium, calcium, or potassium in the blood). SORAFENIB is restricted to use in persons who are sensitive to any of its constituent or have squamous cell lung cancer or already taking carboplatin and paclitaxel.
Drug-Drug Interaction: SORAHEET Tablet may have interaction with anti-cancer medicine (Sorafenib and Paclitaxel), antibiotics (Neomycin), anti-seizure medicine (carbamazepine, phenytoin), an antacid (Omeprazole).
Drug-Food Interaction: The absorption of SORAHEET Tablet gets reduced in presence of food. This is why it is suggested to take SORAFENIB on an empty stomach or 1 or 2 hours after a meal. Additionally, an individual should avoid grapefruit juice as it may increase the amount of drug in the bloodstream.
Drug-Disease Interaction: Do not take SORAHEET Tablet if you have squamous cell lung cancer.